Sfoglia per Autore
Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver
2000 Varani Stefania, Lazzarotto T, Margotti Marzia, Masi Livia, Gramantieri Laura, Bolondi Luigi, Landini MP
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.
2004 Miotto E.; Sabbioni S.; Veronese A.; Calin G.A.; Gullini S.; Liboni A.; Gramantieri L.; Bolondi L.; Ferrazzi E.; Gafa R.; Lanza G.; Negrini M.
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
2004 Piscaglia F.; Donati G.; Gaiani S.; Gramantieri L.; Leoni S.; Mancini M.; Bolondi L.
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation.
2005 Gramantieri L.; Chieco P.; Giovannini C.; Lacchini M.; Treré D.; Grazi G.L.; Venturi A.; Bolondi L.
Improving accuracy in the diagnosis of small HCC (< 20 mm) on cirrhosis by a combined CT-MRI Ultrasound navigation system. Preliminary report of a work in progress.
2006 Vidili G, Piscaglia F, Bazzocchi A, Zironi G, Celli N, Mirarchi M, Lanzi A, Gramantieri L, Golfieri R, Bolondi L
Notch3 intracellular domain accumulates in HepG2 cell line.
2006 Giovannini C.; Lacchini M.; Gramantieri L.; Chieco P.; Bolondi L.
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
2007 Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
2008 Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M.
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.
2009 Gramantieri L; Fornari F; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Croce CM; Bolondi L; Negrini M.
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells.
2009 Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L.
Oncogenic role of miR-483-3p at the IGF2/483 locus.
2010 Veronese A; Lupini L; Consiglio J; Visone R; Ferracin M; Fornari F; Zanesi N; Alder H; D'Elia G; Gramantieri L; Bolondi L; Lanza G; Querzoli P; Angioni A; Croce CM; Negrini M.
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA
2010 Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Fornari, F.; Chieco, P.; Piscaglia, F.; Bolondi, L.
Efficacy of superselective TACE in treatment of HCC
2010 Terzi E, Piscaglia F, Trimarchi C, Golfieri R, Giampalma E, Cappelli A, Renzulli M, Gramantieri L, Pini P, Serio I, Bolondi L
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA
2010 Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Chieco, P.; Marcu, K.B.; Mastroleo, C.; Piscaglia, F.; Bolondi, L.
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
2010 Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L.
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma.
2013 Giovannini C;Baglioni M;Baron Toaldo M;Ventrucci C;D'Adamo S;Cipone M;Chieco P;Gramantieri L;Bolondi L
Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
2014 H. Miyaaki;T. Ichikawa;Y. Kamo;N. Taura;T. Honda;H. Shibata;M. Milazzo;F. Fornari;L. Gramantieri;L. Bolondi;K. Nakao
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
2014 C. Giovannini;M. Minguzzi;M. Baglioni;F. Fornari;F. Giannone;M. Ravaioli;M. Cescon;P. Chieco;L. Bolondi;L. Gramantieri
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma
2014 F. Fornari;M. Milazzo;M. Galassi;E. Callegari;A. Veronese;H. Miyaaki;S. Sabbioni;V. Mantovani;E. Marasco;P. Chieco;M. Negrini;L. Bolondi;L. Gramantieri
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC
2015 Fornari, Francesca; Ferracin, Manuela; Trerè, Davide; Milazzo, Maddalena; Marinelli, Sara; Galassi, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Foschi, Francesco G.; Stefanini, Giuseppe F.; Negrini, Massimo; Bolondi, Luigi; Gramantieri, Laura
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver | Varani Stefania, Lazzarotto T, Margotti Marzia, Masi Livia, Gramantieri Laura, Bolondi Luigi, La...ndini MP | 2000-01-01 | JOURNAL OF MEDICAL VIROLOGY | - | 1.01 Articolo in rivista | - |
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. | Miotto E.; Sabbioni S.; Veronese A.; Calin G.A.; Gullini S.; Liboni A.; Gramantieri L.; Bolondi L....; Ferrazzi E.; Gafa R.; Lanza G.; Negrini M. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. | Piscaglia F.; Donati G.; Gaiani S.; Gramantieri L.; Leoni S.; Mancini M.; Bolondi L. | 2004-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. | Gramantieri L.; Chieco P.; Giovannini C.; Lacchini M.; Treré D.; Grazi G.L.; Venturi A.; Bolondi L. | 2005-01-01 | HUMAN PATHOLOGY | - | 1.01 Articolo in rivista | - |
Improving accuracy in the diagnosis of small HCC (< 20 mm) on cirrhosis by a combined CT-MRI Ultrasound navigation system. Preliminary report of a work in progress. | Vidili G, Piscaglia F, Bazzocchi A, Zironi G, Celli N, Mirarchi M, Lanzi A, Gramantieri L, Golfie...ri R, Bolondi L | 2006-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Notch3 intracellular domain accumulates in HepG2 cell line. | Giovannini C.; Lacchini M.; Gramantieri L.; Chieco P.; Bolondi L. | 2006-01-01 | ANTICANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. | Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Fer...razzi E; Grazi GL; Croce CM; Bolondi L; Negrini M | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. | Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; C...roce CM; Bolondi L; Negrini M. | 2008-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. | Gramantieri L; Fornari F; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Croce CM; Bolon...di L; Negrini M. | 2009-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. | Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; C...roce CM; Tavolari S; Chieco P; Negrini M; Bolondi L. | 2009-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Oncogenic role of miR-483-3p at the IGF2/483 locus. | Veronese A; Lupini L; Consiglio J; Visone R; Ferracin M; Fornari F; Zanesi N; Alder H; D'Elia G; ...Gramantieri L; Bolondi L; Lanza G; Querzoli P; Angioni A; Croce CM; Negrini M. | 2010-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA | Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Fornari, F.; Chieco, P.; Piscaglia, F.; Bolondi, L. | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
Efficacy of superselective TACE in treatment of HCC | Terzi E, Piscaglia F, Trimarchi C, Golfieri R, Giampalma E, Cappelli A, Renzulli M, Gramantieri L..., Pini P, Serio I, Bolondi L | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA | Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Chieco, P.; Marcu, K.B.; Mastroleo, C.; Piscaglia,... F.; Bolondi, L. | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. | Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; G...ramantieri L. | 2010-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. | Giovannini C;Baglioni M;Baron Toaldo M;Ventrucci C;D'Adamo S;Cipone M;Chieco P;Gramantieri L;Bolo...ndi L | 2013-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. | H. Miyaaki;T. Ichikawa;Y. Kamo;N. Taura;T. Honda;H. Shibata;M. Milazzo;F. Fornari;L. Gramantieri;...L. Bolondi;K. Nakao | 2014-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | - |
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. | C. Giovannini;M. Minguzzi;M. Baglioni;F. Fornari;F. Giannone;M. Ravaioli;M. Cescon;P. Chieco;L. B...olondi;L. Gramantieri | 2014-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma | F. Fornari;M. Milazzo;M. Galassi;E. Callegari;A. Veronese;H. Miyaaki;S. Sabbioni;V. Mantovani;E. ...Marasco;P. Chieco;M. Negrini;L. Bolondi;L. Gramantieri | 2014-01-01 | MOLECULAR CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC | Fornari, Francesca; Ferracin, Manuela; Trerè, Davide; Milazzo, Maddalena; Marinelli, Sara; Galass...i, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Foschi, Francesco G.; Stefanini, Giuseppe F.; Negrini, Massimo; Bolondi, Luigi; Gramantieri, Laura | 2015-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | 2015_Fornari-PlosOne.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile